Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21060028 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia
Conditions: Refractory or Recurrent Solid Tumors;   Acute Myelogenous Leukemia
Intervention: Drug: Cediranib, AZD2171, RECENTIN

Study has passed its completion date and status has not been verified in more than two years.